Member Info for CHELSEA7

53k Sell at 6.404, tick down 6.40/6.60

At 6.50

TICK DOWN 6.4/6.8

Not showing here but must be a sell as bid has come down from 6.7 to 6.49/6.53 for a max 150k

Must have just fallen asleep last night after Matts question about how this news affected Scancell, and yes Bermuda I agree with your response, particularly this part ................

"" My own take is simply that it's an endorsement of the ImmunoBody platform from Lindy Durrant's peers and therefore positive news.""

So relevant now too with the SCIB 1 Combo Trial finally receiving the IND and reminding us of the endorsements we received from Keith Flaherty and others concerning our data from the SCIB1 Mono Trial. It sure has been a long period of time from those days, feeding off Lindys presentations around the globe, while progress into Human Trials stalled along with timelines given for each stage.

Looking back many called out the delays, correctly, which I never took on board at the time, I spent too long questioning how the market had valued us incorrectly which stemmed from my lack of experience not only in the share market but with a Biotech in particular.

So nine years here has been one long learning curve for me, from understanding real inflection points and lack of meeting timelines and how the market punishes you for it. Fortunately in the last couple of years I have learnt just how much I didn"t understand which is why I think for many of us with a similar story it is the here and now that matters, putting right where we can the mistaken judgements and be able to see two sides of every discussion while able to draw your own conclusions.

Whilst it is reasonable to argue that past performance could be a guide to the future it just doesn"t make any sense to me that the BOD at this critical time, where funding will be needed way before the early 2021 period once muted, to repeat the culture of false timelines, delay and an ever shrinking M/Cap that has occurred in the past, for whatever reason. So yes this is a Pivotal Year for us and Scancell with the promise of a lot of good news, last year was a Pivotal Year with Vulpes coming on board and next year will be a Pivotal Year too, collecting the most valuable commodity of all........data!!!

The last few RNSs have been...............3rd Feb 2020 7:00 am RNS SCIB1 IND Application Approved
31st Jan 2020 7:00 am RNS Interim Results
20th Jan 2020 7:00 am RNS Third agreement signed for antibody platform
17th Dec 2019 12:44 pm RNS Director's Dealings
16th Dec 2019 7:00 am RNS Second agreement signed for AvidiMab platform

Another week has flown by, we have attended the LSX World Congress in New York, and arrangements for trial sites dor SCIB1 trial must be making progress at a pace, another collaboration will not surprise any of us, and it was only 10 weeks ago that Vulpes increased their holding, and TBH I have been tracking signs of any further Director buying since, apart from the news expected, I was hoping Vulpes would take their holding to 18% with buys around 7p. Now that would IMHO take the SP to a years high, as could any number of new RNSs. ATB

Good question Matt, and I have often felt some of the criticism afforded to certain members of the BOD is at times hysterical, not factual, and in most cases especially over on ADVFN not relevant to the hear and now.

There was a good article in Fierce Biotech today written by Brad Loncar (a name we have seen on Scancell Twitter, discussingthe top IPOs from 2018/2019 and in all cases the companies are in at least Phase 1 trials, with high expectancy from any data they have recorded. I don"t think many here have any illusions as to the imposrtance of us too being in trials, collecting data which will determine our potential worth. We are nearing that stage across three platforms. The current SP reflects our position and there is still uch we don"t know as to what has caused delays, but stillsome will blame JC or CH in sweeping statements to proportion blame and fulfil in many casesa clear agenda in seeing Scancel fail

As I have said the current SP reflects where we are now and I feel we should spend more time focusing on the here and now, risk/reward at current levels, I do not see the purpose of trying to still proportion blame to another company at a different time with high expectations and a share prie suitably inflated. So a simple answer why have faith in Scancell"" perhaps they kmow better where we are at, the capabilities of the company as it has grown and a confidence even in Vilpes/Martin Diggle to secure commercial deals at this stage. I personally don"t feel we have been in a better position before as we are now and NTU know better than our so called self declared experts over on ADVFN how we are set up for the here and now at the prices we have fallen to by delays in the last few years. So why would they have faith...............well it exists because they see more than we do, and are in abetter position to make judgements without any agendas that exist. ATB

Would appear with the glycans agreement NU have a lot of confidence in Scancell to commercialise it. Certainly more confidence than some LTHs hold with our existing platforms.

There have been more than a few occasions where I wondered how much Lindys dual role affected the time she could spend on Scancell, seems clearer now the benefits to Scancell . IMO

Chester, you took the words out of my mouth. Tremendous research from cc, and once again the high regard Lindy is held in shines through. Sometimes that regard seems to make a mockery of the value of the science being developed in Scancell by it"s M/Cap of just only £31m.

Can"t remember a week with so few trades, seems like we are just treading water in this range, but we started the week 6.4/6.5, and although the bid has been pretty much the same, still taking plenty of shares at 6.7p despite showing 6.4, but the ask has increased from 6.46 to 6/98, some 8% odd.

I must have seen four seasons today, torrential rain throughout the night, heavy snow, albeit just for an hour, hailstones and then brilliant sunshine and blue skies in the afternoon. Here"s to more blue!! GN

“Vaccines can trigger immune responses that protect us from diseases such as hepatitis, measles and tetanus, and such immunotherapies also offer an approach for the treatment of cancer, as they are relatively non-toxic and have the potential to protect against cancer recurrence.”

Headcase Cancer Trust's founder Colin Speirs’ wife, Becky, died from GBM in 2010. They met while studying at Nottingham Trent University.

Colin said: “We’re delighted that Headcase continues to fund this genuinely ground-breaking project with NTU and that I, personally, can put something back into the University.

He said: “It’s their radical out-of-the-box thinking that we love; it fits perfectly with Headcase’s strategy to find a cure for this currently incurable disease. We look forward to moving this work, together, into human trials. The future gets written today.”

There certainly is a lot going on behind the scenes.

Great find, as ever cc

Buys 17k....3 Trades

Sells 27k....2 Trades

-,74%, most odd.

And since the tick down to 6.4/7, MMs will still take in excess of 235k at 7p

Every day for the last couple of weeks SCAP are the first MM to open their book at 07.30. They have been behind the larger trades we have seen too. Now they are off the bid, we tick down and they join two others on the Ask at 7p.

Just MO, but perhaps time for a larger buy to show, latest trade a 15k Buy at 6.98

Just for a few.......................

Latest Trades
Date & Time Volume Price
27/02/2020 09:22 2,149 6.98

Thanks

It"s snowing!!

Correct, and that is why I say there is a lot of conflicting information., which doesn"t surprise me as they are still finding so much out. Some say go to your GP some say don"t and self isolate. I think Donald Trump has called it right, get on with it!!

Inan, that is why the Goverments policy is contain and delay, so when the traditional flu season is over the will have more hospital beds. Interestingly for the first time I heard them say by then hopefully there will be a vaccine. Articles I have seen have suggested it could take a year to find a suitable treatment. So yes there is a lot of conflicting information.

Yeah I did, and for the first time The District Nurses came in November, the last few years not until Jan/February.

Funny enough,as ever, I was really ill after having it for a few weeks, which is always the case, but every consultant, oncologist or Doctor I see say there is no connection to the jab and any after effects that arise. Every so often even with taking anti-biotics 24/7, two different types I need to go in to hospital for a few days to be given intravenous boosts. The remarkable thing is , apart from needing occasional boosts, they still work on me, long may that continue.

Well disappointed this morning, the snow that was promised hasn"t materialised, but replaced by
heavy rain, what"s new.

Still not wasted time, Sky News showed a Coronavirus Outbreak Special, and it explained very well what we need snd should know. It might well end up a pandemic, the trouble is countries have to prepare for worst case scenarios, but what concerned me was the advice being given to us all is in large contradictory, and the U.K still has just 13 cases confirmed of which nobody has died (yet).

Stlill for us older ones, the flu is our biggest challenge, simply as LL explained her father passed with pneumonia, something I had 3 times in a short period 8 years ago and spent many weeks in Intensive Care as a result. So wash your hands, carry on, we are nothing but stoic, and don"t panic Captain Mainwaring as it seems many are trying to do.

By the time they covered the floods around the country, I felt I was watching the Doomsday Book, which is probably why I choose to catch the news on a Sunday, Breaking News updates are sufficient for me all week.

Very little to read into the market this week here, except trades are few and far between, and as a result no real pressure on the Bid or Ask, as we are seeing. It wasn"t so long ago we got news, and I just wonder if in this aim market which is so dependant on news, whether you can ever get enough news to keep the momentum flowing?? But things change very quickly on AIM, as we know, news can arrive anytime, lets hope we get the rub of the green. Have a good day all.